Literature DB >> 12604402

Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells.

Wichard Vogel1, Frank Grünebach, Conrad A Messam, Lothar Kanz, Wolfram Brugger, Hans-Jörg Bühring.   

Abstract

BACKGROUND AND OBJECTIVES: Mesenchymal stem cells (MSC) and neural progenitor cells (NPC) are pluripotent cells. The former can give rise to myocytes, chondrocytes, adipocytes, and osteogenic cells, while the latter can give rise to astrocytes, neurons, and oligodendrocytes. The aim of this study was to analyze and compare the antigen expression patterns of MSC and NPC. DESIGN AND METHODS: Human bone marrow-derived MSC and NPC were analyzed by flow cytometry and immunocytochemistry using a variety of unique monoclonal antibodies (57D2, W4A5, W8B2) generated in our laboratory. In addition, the expression profile of CD antigens and intracellular differentiation markers was analyzed.
RESULTS: We show for the first time that CD10+, CD13+, CD61+, CD90+, CD105 (endoglin)+, CD45-, CD34-, and CD133- MSC also expressed CD109, CD140b (PDGF-RB), CD164, and CD172a (SIRPa). In addition, we found heterogeneity of MSC as demonstrated by the preferential expression of nestin and W8B2 antigen on distinct MSC subpopulations. Morphologically, these populations comprised small single cells and larger cells with polygonal appearance. NPC expressed high levels of CD56, CD90 and nestin and moderate levels of CD15, W4A5, and 57D2 antigens. In contrast, CD133 and CD172 were found only on NPC subpopulations. INTERPRETATION AND
CONCLUSIONS: Our data demonstrate nestin expression in most NPC as well as in immature MSC subpopulations. MSC and NPC subpopulations can now be distinguished using our novel antibodies W8B2, 57D2, and W4A5.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604402

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  62 in total

1.  The use of four-colour immunofluorescence techniques to identify mesenchymal stem cells.

Authors:  Matthias Schieker; Christoph Pautke; Katharina Reitz; Indradeo Hemraj; Peter Neth; Wolf Mutschler; Stefan Milz
Journal:  J Anat       Date:  2004-02       Impact factor: 2.610

2.  Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?

Authors:  Ulrich Lindner; Jan Kramer; Jürgen Rohwedel; Peter Schlenke
Journal:  Transfus Med Hemother       Date:  2010-03-15       Impact factor: 3.747

3.  Mesenchymal stem cells or cardiac progenitors for cardiac repair? A comparative study.

Authors:  Remco Koninckx; Annick Daniëls; Severina Windmolders; Françoise Carlotti; Urbain Mees; Paul Steels; Jean-Luc Rummens; Marc Hendrikx; Karen Hensen
Journal:  Cell Mol Life Sci       Date:  2010-10-24       Impact factor: 9.261

Review 4.  Regenerative therapy after cancer: what are the risks?

Authors:  Vera S Donnenberg; Ludovic Zimmerlin; Joseph Peter Rubin; Albert D Donnenberg
Journal:  Tissue Eng Part B Rev       Date:  2010-11-02       Impact factor: 6.389

5.  Isolation of renal progenitor cells from adult human kidney.

Authors:  Benedetta Bussolati; Stefania Bruno; Cristina Grange; Stefano Buttiglieri; Maria Chiara Deregibus; Dario Cantino; Giovanni Camussi
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

6.  Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells.

Authors:  J Kim; Y Lee; H Kim; K J Hwang; H C Kwon; S K Kim; D J Cho; S G Kang; J You
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

7.  Neural progenitor cells from postmortem adult human retina.

Authors:  E J Mayer; D A Carter; Y Ren; E H Hughes; C M Rice; C A Halfpenny; N J Scolding; A D Dick
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

8.  Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1.

Authors:  Venkata Lokesh Battula; Sabrina Treml; Petra M Bareiss; Friederike Gieseke; Helene Roelofs; Peter de Zwart; Ingo Müller; Bernhard Schewe; Thomas Skutella; Willem E Fibbe; Lothar Kanz; Hans-Jörg Bühring
Journal:  Haematologica       Date:  2008-12-09       Impact factor: 9.941

Review 9.  Brain mesenchymal stem cells: The other stem cells of the brain?

Authors:  Florence Appaix; Marie-France Nissou; Boudewijn van der Sanden; Matthieu Dreyfus; François Berger; Jean-Paul Issartel; Didier Wion
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

10.  Quantitative proteomics analysis of chondrogenic differentiation of C3H10T1/2 mesenchymal stem cells by iTRAQ labeling coupled with on-line two-dimensional LC/MS/MS.

Authors:  Yu-hua Ji; Ju-ling Ji; Fen-yong Sun; Yao-ying Zeng; Xian-hui He; Jing-xian Zhao; Yu Yu; Shou-he Yu; Wei Wu
Journal:  Mol Cell Proteomics       Date:  2009-12-15       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.